BTAI
BioXcel Therapeutics, Inc. · Healthcare
Insiders sold $43K net in the last 90 days ·4 sellers, 0 buyers· 4 of 4 sales under Rule 10b5-1 plans· latest Form 4 filed May 22, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$43K
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Jun 17, 2026
Yocca Frank
BioXcel Therapeutics, Inc. (BTAI) has 21 SEC Form 4 filings (33 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jun 17, 2026.
Inside the rolling window, 4 insiders at BioXcel Therapeutics, Inc. reported no open-market purchases and 4 open-market sales totaling $43K. The most recent open-market filing is a sale of 6,845 shares by Chief Scientific Officer Yocca Frank, dated May 20, 2026, worth $7K.
- Industry:Biotechnology
- CEO:Vimal D. Mehta
- Employees:29
- HQ:New Haven, CT, US
- IPO:2018-03-08
| Source | |||||||
|---|---|---|---|---|---|---|---|
Yocca FrankFirst filing | Chief Scientific Officer | Sale | 6,845 | $7K | May 22 | -95.5% | SEC ↗ |
Rodriguez JavierFirst filing | See Remarks | Sale | 6,560 | $7K | May 22 | -95.5% | SEC ↗ |
Steinhart Richard IFirst filing | Chief Financial Officer | Sale | 6,845 | $7K | May 22 | -95.5% | SEC ↗ |
Mehta VimalFirst filing | CEO and President | Sale | 19,419 | $21K | May 22 | -95.5% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does BTAI have?
BioXcel Therapeutics, Inc. (BTAI) has 21 SEC Form 4 filings (33 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Jun 17, 2026.
When was the most recent SEC Form 4 filing for BTAI?
The most recent Form 4 filing for BTAI on Tracefour is dated Jun 17, 2026.
What is the net insider flow at BTAI over the last 6 months?
Over the trailing 180 days, insiders at BTAI have net sold $43K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at BTAI in the current window?
Inside the rolling window, insiders at BTAI bought $0 and sold $43K based on SEC Form 4 filings.
Can I get alerts for BTAI insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at BioXcel Therapeutics, Inc. (BTAI). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
BioXcel Therapeutics, Inc. is in the Healthcare sector.